Mark Biondo

946 total citations
25 papers, 702 citations indexed

About

Mark Biondo is a scholar working on Immunology, Surgery and Genetics. According to data from OpenAlex, Mark Biondo has authored 25 papers receiving a total of 702 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Immunology, 6 papers in Surgery and 6 papers in Genetics. Recurrent topics in Mark Biondo's work include Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Mark Biondo is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Immunotherapy and Immune Responses (5 papers) and Helicobacter pylori-related gastroenterology studies (4 papers). Mark Biondo collaborates with scholars based in Australia, United States and Germany. Mark Biondo's co-authors include Frank Alderuccio, Samantha J. Busfield, G Vairo, Ban Hock Toh, Jennifer M. Rolland, Robyn E. O’Hehir, Alessandra Sandrini, Belinda J. Hales, Angel F. López and John Aubrey Douglass and has published in prestigious journals such as Blood, The Journal of Immunology and PLoS ONE.

In The Last Decade

Mark Biondo

23 papers receiving 692 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Biondo Australia 14 297 183 165 163 151 25 702
Akihito Fujimi Japan 9 152 0.5× 275 1.5× 424 2.6× 94 0.6× 41 0.3× 41 739
T Nakahata Japan 13 309 1.0× 106 0.6× 278 1.7× 72 0.4× 93 0.6× 30 634
Paloma Bárcena Spain 19 372 1.3× 198 1.1× 309 1.9× 22 0.1× 51 0.3× 24 859
H.-P. Horny Germany 13 169 0.6× 121 0.7× 51 0.3× 28 0.2× 35 0.2× 32 563
Derek Brown United Kingdom 9 301 1.0× 69 0.4× 108 0.7× 35 0.2× 19 0.1× 12 637
Angela Burman United Kingdom 11 450 1.5× 181 1.0× 248 1.5× 46 0.3× 19 0.1× 14 757
Giulia Spallone Italy 12 218 0.7× 136 0.7× 21 0.1× 23 0.1× 54 0.4× 27 609
Gitte De Boeck Belgium 9 204 0.7× 159 0.9× 33 0.2× 30 0.2× 70 0.5× 9 548
Barbara Brandner Austria 7 176 0.6× 229 1.3× 23 0.1× 41 0.3× 619 4.1× 7 895

Countries citing papers authored by Mark Biondo

Since Specialization
Citations

This map shows the geographic impact of Mark Biondo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Biondo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Biondo more than expected).

Fields of papers citing papers by Mark Biondo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Biondo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Biondo. The network helps show where Mark Biondo may publish in the future.

Co-authorship network of co-authors of Mark Biondo

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Biondo. A scholar is included among the top collaborators of Mark Biondo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Biondo. Mark Biondo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Biondo, Mark, et al.. (2025). CSL040 ameliorates primary graft dysfunction in pre-clinical models of lung transplantation. Immunobiology. 230(4). 152991–152991.
2.
Lee, Ming-Chin, Stacey N. Keenan, Adrian Achuthan, et al.. (2025). Therapeutic blockade of CCL17 in obesity-exacerbated osteoarthritic pain and disease. PLoS ONE. 20(1). e0317399–e0317399. 2 indexed citations
3.
Achuthan, Adrian, Mark Biondo, Bronwyn A. Kingwell, et al.. (2023). The GM-CSF/CCL17 pathway in obesity-associated osteoarthritic pain and disease in mice. Osteoarthritis and Cartilage. 31(10). 1327–1341. 6 indexed citations
4.
Pawaskar, Dipti, Xi Chen, Frauke May, et al.. (2021). Pharmacokinetic/pharmacodynamic modeling for dose selection for the first‐in‐human trial of the activated Factor XII inhibitor garadacimab (CSL312). Clinical and Translational Science. 15(3). 709–720. 16 indexed citations
5.
Searle, Amy, Yung‐Chih Chen, Maria Wallert, et al.. (2021). Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques. Thrombosis and Haemostasis. 122(2). 196–207. 12 indexed citations
6.
Xie, Liji, Mark Biondo, Samantha J. Busfield, et al.. (2017). CD123 target validation and preclinical evaluation of ADCC activity of anti-CD123 antibody CSL362 in combination with NKs from AML patients in remission. Blood Cancer Journal. 7(6). e567–e567. 36 indexed citations
8.
Oon, Shereen, Huy Huynh, Tsin Yee Tai, et al.. (2016). A cytotoxic anti-IL-3Rα antibody targets key cells and cytokines implicated in systemic lupus erythematosus. JCI Insight. 1(6). e86131–e86131. 26 indexed citations
9.
Nievergall, Eva, John Reynolds, Chung Hoow Kok, et al.. (2016). TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy. Leukemia. 30(6). 1263–1272. 38 indexed citations
10.
Busfield, Samantha J., Mark Biondo, Hayley S. Ramshaw, et al.. (2014). Targeting of acute myeloid leukemia in vitro and in vivo with an anti-CD123 mAb engineered for optimal ADCC. Leukemia. 28(11). 2213–2221. 106 indexed citations
11.
Nievergall, Eva, John Reynolds, Chung Hoow Kok, et al.. (2014). High Plasma Levels of TGF-α and IL-6 at Diagnosis Predict Early Molecular Response Failure and Transformation in CML. Blood. 124(21). 1788–1788.
12.
Nievergall, Eva, Hayley S. Ramshaw, Agnes S. M. Yong, et al.. (2013). Monoclonal antibody targeting of IL-3 receptor α with CSL362 effectively depletes CML progenitor and stem cells. Blood. 123(8). 1218–1228. 79 indexed citations
13.
Davies, Janet M., Thanh Dang, Astrid Voskamp, et al.. (2011). Functional immunoglobulin E cross‐reactivity between Pas n 1 of Bahia grass pollen and other group 1 grass pollen allergens. Clinical & Experimental Allergy. 41(2). 281–291. 31 indexed citations
14.
O’Hehir, Robyn E., Leanne M. Gardner, Maria P. de Leon, et al.. (2009). House Dust Mite Sublingual Immunotherapy: The Role for Transforming Growth Factor–β and Functional Regulatory T Cells. American Journal of Respiratory and Critical Care Medicine. 180(10). 936–947. 138 indexed citations
15.
Biondo, Mark, et al.. (2006). Prednisolone promotes remission and gastric mucosal regeneration in experimental autoimmune gastritis. The Journal of Pathology. 209(3). 384–391. 13 indexed citations
16.
Alderuccio, Frank, Kim Murphy, Mark Biondo, Judith Field, & Ban‐Hock Toh. (2005). Reversing the Autoimmune Condition: Experience with Experimental Autoimmune Gastritis. International Reviews of Immunology. 24(1-2). 135–155. 4 indexed citations
17.
Field, Judith, Mark Biondo, Kieran A. Murphy, Frank Alderuccio, & B H Toh. (2005). Experimental Autoimmune Gastritis: Mouse Models Of Human Organ-specific Autoimmune Disease. International Reviews of Immunology. 24(1-2). 93–110. 14 indexed citations
18.
Alderuccio, Frank, et al.. (2002). Animal Models of Human Disease: Experimental Autoimmune Gastritis—A Model for Autoimmune Gastritis and Pernicious Anemia. Clinical Immunology. 102(1). 48–58. 50 indexed citations
19.
Biondo, Mark, et al.. (2001). Local Transgenic Expression of Granulocyte Macrophage-Colony Stimulating Factor Initiates Autoimmunity. The Journal of Immunology. 166(3). 2090–2099. 64 indexed citations
20.
Pan, Ruiyan, et al.. (1995). [Effect of gonadotrophins, testosterone and growth hormone on spermatogenesis in two hypophysectomy patients].. PubMed. 24(4). 357–61. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026